Boulesteix 1995.

Methods	RCT
Participants	French multicentre trial of children 6 months to 6 years old
Interventions	Cefpodoxime 4 mg/kg twice daily for 5 days versus cefixime 4 mg/kg twice daily for 8 days
Outcomes	Absence or improvement of signs and symptoms at 8 to 10 days and no recurrence at 30 to 40 days after study entry
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Low risk
Blinding (performance bias and detection bias) Treatment failure at 1 month or less	High risk
Incomplete outcome data (attrition bias) Treatment failure at 1 month or less	Low risk
Selective reporting (reporting bias)	Low risk
Other bias	Unclear risk	Funding not declared